Prognostic factors associated with clinical pregnancy in in vitro fertilization using pituitary down-regulation with depot and daily low-dose luteal phase gonadotropin releasing hormone agonists: A single center's experience

Prognostic factors associated with clinical pregnancy in in vitro fertilization using pituitary down-regulation with depot and daily low-dose luteal phase gonadotropin releasing hormone agonists: A single center's experience

Bibliographic Details
Main Authors:	Liao, Caiyun, Huang, Rui, Scherer, Roberta W., Liang, Xiao-Yan
Format:	Online
Language:	English
Published:	Medknow Publications & Media Pvt Ltd 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381380/

Similar Items

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
by: Keane, Fergus, et al.
Published: (2016)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
by: Inamdar, Dattaprasad B, et al.
Published: (2012)

Luteal estradiol supplementation in gonadotropin-releasing hormone antagonist cycles for infertile patients in vitro fertilization
by: Kwon, Su-Kyoung, et al.
Published: (2013)

Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort
by: Crawford, E David, et al.
Published: (2011)

Gonadotropin releasing hormone agonists: Expanding vistas
by: Magon, Navneet
Published: (2011)

Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls
by: Shiasi Arani, Kobra, et al.
Published: (2015)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
by: Tehraninejad, Ensieh Sh., et al.
Published: (2010)

Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case
by: Huang, Tsung-Yi, et al.
Published: (2013)

Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?
by: Gurbuz, Ali Sami, et al.
Published: (2016)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
by: Jumpei Asakawa, et al.
Published: (2018-07-01)

Artificial Endometrial Preparation for Frozen-Thawed Embryo Transfer with or without Pretreatment with Depot Gonadotropin Releasing Hormone Agonist in Women with Regular Menses
by: Azimi Nekoo, Elham, et al.
Published: (2015)

Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
by: Choi, Seungtaek, et al.
Published: (2011)

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Han, Eun Jin, et al.
Published: (2013)

A Case of Thromboembolism After Injection of Gonadotropin-releasing Hormone Agonist
by: Zhou, Feng, et al.
Published: (2016)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS
by: Eftekhar, Maryam, et al.
Published: (2016)

Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
by: Kumar, K. V. S. Hari, et al.
Published: (2013)

A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
by: Hoseini, Fatemeh Sadat, et al.
Published: (2014)

Gonadotropin-inhibitory hormone action in the brain and pituitary
by: Ubuka, Takayoshi, et al.
Published: (2012)

Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner
by: Moretti, Roberta M., et al.
Published: (2014)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Jung, Mo Kyung, et al.
Published: (2014)

Kisspeptin regulates gonadotropin-releasing hormone secretion in gonadotropin-releasing hormone/enhanced green fluorescent protein transgenic rats☆
by: Xue, Haogang, et al.
Published: (2013)

Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?
by: Gutgutia, Rohit, et al.
Published: (2014)

Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment
by: Taktaz, T., et al.
Published: (2015)

Different gonadotropin releasing hormone agonist doses for the final oocyte maturation in high-responder patients undergoing in vitro fertilization/intra-cytoplasmic sperm injection
by: Pabuccu, Emre Goksan, et al.
Published: (2015)

Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer
by: Zhang, John
Published: (2016)

Effect of lithium chloride on the luteal steroidogenesis in gonadotropin-stimulated rat
by: Khodadadi, Maryam, et al.
Published: (2012)

Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
by: Kim, Han Kyul, et al.
Published: (2011)

Epigenetic Control of Gonadotropin Releasing Hormone Neurons
by: Kurian, Joseph R., et al.
Published: (2013)

Gonadotropin-releasing hormone analogs: Understanding advantages and limitations
by: Kumar, Pratap, et al.
Published: (2014)

Alterations in Hypothalamus-Pituitary-Adrenal/Thyroid Axes and Gonadotropin-Releasing Hormone in the Patients with Primary Insomnia: A Clinical Research
by: Xia, Lan, et al.
Published: (2013)

Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
by: Mahajan, Nalini, et al.
Published: (2016)

Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols
by: Malhotra, Neena, et al.
Published: (2013)

Semaphorin Signaling in the Development and Function of the Gonadotropin Hormone-Releasing Hormone System
by: Messina, Andrea, et al.
Published: (2013)

Effects of Gonadotropin-Releasing Hormone Agonist Therapy on Body Mass Index and Height in Girls with Central Precocious Puberty
by: Lee, Seung Jae, et al.
Published: (2012)

Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry
by: Jespersen, Christina Gade, et al.
Published: (2012)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
by: Rabati, Behnaz Khani, et al.
Published: (2012)

Increased Risk of Pneumonia in Patients Receiving Gonadotropin-Releasing Hormone Agonists for Prostate Cancer
by: Chung, Shiu-Dong, et al.
Published: (2014)

Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome
by: Comba, Cihan, et al.
Published: (2013)

Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
by: Hae Sang Lee, et al.

Effect of vaginal estriol use in total laparoscopic hysterectomy with gonadotropin-releasing hormone agonist therapy
by: Go Hirata, et al.
Published: (2018-01-01)